Richter Jumps as FDA Approves Expanded Use of Blockbuster Drug

Bookmark
(Bloomberg) -- Gedeon Richter Nyrt., eastern Europe’s largest drugmaker, rallied the most since July after the U.S. approved the expanded use of its blockbuster anti-psychotic Vraylar.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.